Advanced Medical Solutions Group Regulatory News (AMS)

8 March 2023

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1. Deferred Share Bonus Scheme

2. Enterprise Management Incentive Scheme

3. Company Share Option Plan

4. Unapproved Executive Share Option Scheme

5. Long Term Incentive Plan

6. Deferred Annual Bonus Scheme

Period of return:

From:

6 September 2022

To:

5 March 2023

Balance of unallotted securities under scheme(s) from previous return:

1. 186,786

2. Nil

3. 214,337

4. 671,754

5. 278,220

6. 248,616

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 34,107

2. Nil

3. 32,084

4. 84,802

5. 4,113

6. 2,275

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 152,679

2. Nil

3. 182,253

4. 586,952

5. 274,107

6. 246,341

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Matthew Neal / Lucy Featherstone

Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Gary Clarence / David Anderson

HSBC Bank plc (Broker)

Tel: +44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish